Max Warncke
Impact in
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Nephrology top 10%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
-
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 5
- IL-33, ST2, and ILC Pathways 1
-
- Renal and related cancers 1
- RNA Interference and Gene Delivery 1
- Co-authors
- Christoph Heusser (2 shared papers)Frank Kolbinger (2 shared papers)M. Coulot (1 shared paper)Thomas Calzascia (1 shared paper)Sabina Pfister (1 shared paper)Kea Martin (1 shared paper)Jianping Li (1 shared paper)Ulrike Naumann (1 shared paper)
- Journals
- JCI Insight (1 paper)The Journal of Immunology (1 paper)Cytokine (1 paper)Cancer Immunology Immunotherapy (1 paper)Journal of Immunological Methods (1 paper)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Max Warncke
9 papers receiving 322 citations
Peers
Comparison fields: 5 of 58
- Immunology 180
- Nephrology 50
- Transplantation 16
- Radiology, Nuclear Medicine and Imaging 84
- Virology 11
Countries citing papers authored by Max Warncke
This map shows the geographic impact of Max Warncke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Warncke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Warncke more than expected).
Fields of papers citing papers by Max Warncke
This network shows the impact of papers produced by Max Warncke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Warncke. The network helps show where Max Warncke may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Warncke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 111 | |
| 2 | 2018 | 74 | |
| 3 | 2012 | 72 | |
| 4 | 2012 | 35 | |
| 5 | 2005 | 15 | |
| 6 | 2010 | 12 | |
| 7 | 2009 | 5 | |
| 8 | 2004 | 4 | |
| 9 | 2006 | 1 |
About Max Warncke
Max Warncke is a scholar working on Immunology, Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging and Nephrology, having authored 9 papers that have together received 329 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers), CAR-T cell therapy research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), IL-33, ST2, and ILC Pathways (1 paper), Renal and related cancers (1 paper), Virus-based gene therapy research (1 paper) and RNA Interference and Gene Delivery (1 paper). The work is most often cited by research in Immunology (180 citations), Nephrology (50 citations), Transplantation (16 citations), Radiology, Nuclear Medicine and Imaging (84 citations) and Virology (11 citations). Max Warncke has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Christoph Heusser, Frank Kolbinger, M. Coulot, Thomas Calzascia, Sabina Pfister, Kea Martin, Jianping Li, Ulrike Naumann, Swann Gaulis and Kirsten D. Mertz. Their work appears in journals such as JCI Insight, The Journal of Immunology, Cytokine, Cancer Immunology Immunotherapy and Journal of Immunological Methods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.